- Home
- CTNT vs SXTP Comparison
CTNT vs SXTP Comparison
Compare CTNT & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNT | SXTP |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.6M |
| IPO Year | 2023 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CTNT | SXTP |
|---|---|---|
| Price | $0.24 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.10 |
| AVG Volume (30 Days) | ★ 745.2K | 44.4K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.74 | 36.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,288,536.00 | $1,005,471.00 |
| Revenue This Year | $42.49 | $33.92 |
| Revenue Next Year | $22.22 | $51.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 182.69 | 65.49 |
| 52 Week Low | $0.02 | $0.34 |
| 52 Week High | $4.21 | $8.62 |
Technical Indicators
Market Signals| Indicator | CTNT | SXTP |
|---|---|---|
| Relative Strength Index (RSI) | 17.69 | 31.69 |
| Support Level | $0.02 | $0.90 |
| Resistance Level | $1.55 | $1.62 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 0.00 | 1.25 |
Price Performance
Historical ComparisonAbout CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.